Phreesia (NYSE:PHR) Given “Buy” Rating at Needham & Company LLC

Phreesia (NYSE:PHRGet Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. They currently have a $29.00 price objective on the stock. Needham & Company LLC’s target price would indicate a potential upside of 53.28% from the company’s current price.

Several other research firms have also commented on PHR. DA Davidson restated a “neutral” rating and issued a $32.00 price objective on shares of Phreesia in a research report on Friday, March 15th. Robert W. Baird upped their target price on Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, March 18th. JMP Securities upped their target price on Phreesia from $28.00 to $30.00 and gave the stock a “market outperform” rating in a research note on Thursday, March 21st. Truist Financial began coverage on Phreesia in a research note on Monday, February 26th. They set a “buy” rating and a $35.00 target price for the company. Finally, Raymond James reaffirmed an “outperform” rating and set a $30.00 target price (up from $25.00) on shares of Phreesia in a research note on Friday, March 15th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.38.

Get Our Latest Stock Analysis on Phreesia

Phreesia Trading Down 11.2 %

Phreesia stock opened at $18.92 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia has a 12 month low of $12.05 and a 12 month high of $34.98. The stock’s 50 day simple moving average is $22.55 and its two-hundred day simple moving average is $22.68. The firm has a market cap of $1.08 billion, a PE ratio of -8.72 and a beta of 0.95.

Phreesia (NYSE:PHRGet Free Report) last released its quarterly earnings data on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.51) by $0.16. Phreesia had a negative return on equity of 46.81% and a negative net margin of 31.87%. The business had revenue of $101.20 million for the quarter, compared to analyst estimates of $100.94 million. During the same quarter in the prior year, the firm posted ($0.70) EPS. The business’s quarterly revenue was up 20.8% compared to the same quarter last year. Analysts anticipate that Phreesia will post -1.48 earnings per share for the current year.

Insider Activity at Phreesia

In related news, SVP Amy Beth Vanduyn sold 3,354 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total value of $75,867.48. Following the completion of the transaction, the senior vice president now directly owns 123,463 shares of the company’s stock, valued at approximately $2,792,733.06. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Phreesia news, General Counsel Allison C. Hoffman sold 5,549 shares of the company’s stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total value of $125,518.38. Following the completion of the sale, the general counsel now directly owns 141,485 shares in the company, valued at approximately $3,200,390.70. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Amy Beth Vanduyn sold 3,354 shares of the company’s stock in a transaction on Monday, April 8th. The shares were sold at an average price of $22.62, for a total value of $75,867.48. Following the completion of the sale, the senior vice president now owns 123,463 shares of the company’s stock, valued at $2,792,733.06. The disclosure for this sale can be found here. In the last ninety days, insiders sold 82,467 shares of company stock valued at $1,895,776. 5.80% of the stock is owned by insiders.

Institutional Trading of Phreesia

Several large investors have recently added to or reduced their stakes in PHR. International Assets Investment Management LLC grew its holdings in shares of Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after purchasing an additional 1,411 shares during the period. Acadian Asset Management LLC purchased a new position in shares of Phreesia during the 3rd quarter worth $53,000. Russell Investments Group Ltd. grew its holdings in shares of Phreesia by 5,462.3% during the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after purchasing an additional 3,769 shares during the period. EntryPoint Capital LLC purchased a new position in shares of Phreesia during the 1st quarter worth $169,000. Finally, Quadrature Capital Ltd purchased a new position in shares of Phreesia during the 1st quarter worth $202,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

About Phreesia

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Featured Stories

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.